These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 31963859)

  • 21. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes.
    Yücel G; Zhao Z; El-Battrawy I; Lan H; Lang S; Li X; Buljubasic F; Zimmermann WH; Cyganek L; Utikal J; Ravens U; Wieland T; Borggrefe M; Zhou XB; Akin I
    Sci Rep; 2017 Jun; 7(1):2935. PubMed ID: 28592841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Electrophysiological identification of human induced pluripotent stem cell-derived cardiomyocytes].
    Zhang HY; Zhang TT; Machuki JO; Wu LJ; Sun H
    Sheng Li Xue Bao; 2018 Jun; 70(3):281-286. PubMed ID: 29926069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
    El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
    Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recording of multiple ion current components and action potentials in human induced pluripotent stem cell-derived cardiomyocytes via automated patch-clamp.
    Mann SA; Heide J; Knott T; Airini R; Epureanu FB; Deftu AF; Deftu AT; Radu BM; Amuzescu B
    J Pharmacol Toxicol Methods; 2019; 100():106599. PubMed ID: 31228558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome.
    Guo F; Sun Y; Wang X; Wang H; Wang J; Gong T; Chen X; Zhang P; Su L; Fu G; Su J; Yang S; Lai R; Jiang C; Liang P
    Circ Res; 2019 Jan; 124(1):66-78. PubMed ID: 30582453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid-Sensitive Ion Channels Are Expressed in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Zhang XH; Šarić T; Mehrjardi NZ; Hamad S; Morad M
    Stem Cells Dev; 2019 Jul; 28(14):920-932. PubMed ID: 31119982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human pluripotent stem cell-derived cardiomyocytes: response to TTX and lidocain reveals strong cell to cell variability.
    Sheng X; Reppel M; Nguemo F; Mohammad FI; Kuzmenkin A; Hescheler J; Pfannkuche K
    PLoS One; 2012; 7(9):e45963. PubMed ID: 23029342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
    Prajapati C; Ojala M; Aalto-Setälä K
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Particulate matter 2.5 induced arrhythmogenesis mediated by TRPC3 in human induced pluripotent stem cell-derived cardiomyocytes.
    Cai C; Huang J; Lin Y; Miao W; Chen P; Chen X; Wang J; Chen M
    Arch Toxicol; 2019 Apr; 93(4):1009-1020. PubMed ID: 30806761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform.
    Lodrini AM; Barile L; Rocchetti M; Altomare C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.
    Shaheen N; Shiti A; Huber I; Shinnawi R; Arbel G; Gepstein A; Setter N; Goldfracht I; Gruber A; Chorna SV; Gepstein L
    Stem Cell Reports; 2018 Jun; 10(6):1879-1894. PubMed ID: 29754959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Wei H; Wu J; Liu Z
    Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene Transfer in Cardiomyocytes Derived from ES and iPS Cells.
    Stillitano F; Karakikes I; Hajjar RJ
    Methods Mol Biol; 2017; 1521():183-193. PubMed ID: 27910049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.